Dynamic Technology Lab Private Ltd Takes $356,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Dynamic Technology Lab Private Ltd acquired a new stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 16,929 shares of the company's stock, valued at approximately $356,000.

Several other hedge funds have also added to or reduced their stakes in PAHC. FMR LLC grew its holdings in shares of Phibro Animal Health by 22.7% in the third quarter. FMR LLC now owns 39,310 shares of the company's stock worth $885,000 after acquiring an additional 7,270 shares during the period. BNP Paribas Financial Markets grew its stake in shares of Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after purchasing an additional 729 shares during the period. Zacks Investment Management purchased a new stake in shares of Phibro Animal Health during the 3rd quarter valued at about $274,000. Barclays PLC increased its stake in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after purchasing an additional 29,271 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock valued at $11,430,000 after purchasing an additional 27,201 shares during the period. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Stock Down 4.9 %

NASDAQ PAHC traded down $0.87 on Tuesday, reaching $17.04. 54,781 shares of the stock traded hands, compared to its average volume of 189,138. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company has a fifty day moving average price of $22.11 and a 200-day moving average price of $22.43. The company has a market cap of $690.29 million, a price-to-earnings ratio of 35.51, a PEG ratio of 0.45 and a beta of 0.63. Phibro Animal Health Co. has a 12 month low of $12.30 and a 12 month high of $26.55.

Remove Ads

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, research analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.82%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health's dividend payout ratio is currently 100.00%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Morgan Stanley boosted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Finally, StockNews.com lowered shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research report on Tuesday, March 25th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $21.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.